mean age, 60.08 years; range, 43-88 years) who underwent LEA due to DFU between March 2011 and November 2015 were evaluated. The patients were divided into minor (Group 1, n = 75) and major (Group 2, n = 32) amputation groups. A minor LEA was defined as any amputation distal to the ankle joint, whereas a major LEA was any amputation through or proximal to the ankle joint (11) . The general state of the patients and their extremities, such as peripheral vascular status, neuropathy, and intraoperative tissues, were considered as the criteria of the amputation levels. Foot lesions of the patients were classified according to the Wagner system: Grade 0-skin lesions absent, hyperkeratosis below or above bony prominences; Grade 1-skin and immediate subcutaneous tissue are ulcerated; Grade 2-lesions are deeper and may penetrate to tendon, bone, or joint capsule; Grade 3-deep tissues are always involved, osteomyelitis may be present; Grade 4-gangrene of some portion of the toes or forefoot; Grade 5-the entire foot is gangrenous (12) .
The demographic data of the patients were recorded. On clinical evaluation, the education level of the patient, smoking history, history of foot trauma, comorbidities, presence of improper foot care, duration of DM diagnosis, duration of DFU presence, peripheral neuropathy, and peripheral arterial disease (PAD) were investigated.
The peripheral vascular status was assessed by palpation of the dorsalis pedis and posterior tibial pulses on both feet. The presence of two or fewer of the four pedal pulses indicated PAD. In addition, to determine peripheral vascular history, the patients were asked whether they had undergone any previous peripheral bypass surgery or peripheral angioplasty (1, 7) . Diabetic peripheral sensory neuropathy was defined as the inability to perceive pressure with an amount of 10 g using a nylon monofilament test (5) . The test was performed at three sites (two plantar, one dorsal) of each foot while the patient's eyes were closed (2, 13) . The presence of associated comorbidities, including renal diseases and cardiac/pulmonary/endocrinological conditions, was examined.
Blood parameters were investigated, such as glycated hemoglobin (HbA1c), preoperative leukocyte count (WBC), sedimentation, C-reactive protein (CRP), and serum albumin levels. Blood sugar was similarly investigated, as to whether it was regulated or not. Blood sugar regulation was assessed according to patients' blood sugar and HbA1c levels. In addition, we recorded the type of surgical interventions performed, the results of deep tissue culture received intraoperatively, and the length of hospitalization.
Statistical analysis
Statistical analysis was performed using IBM SPSS 21.0 (IBM, Armonk, NY, USA). Frequency analysis was performed for categorical variables. The data were expressed as numbers and percentages. Paired Student's t-tests and Pearson's chi-square tests were used to compare categorical data. P < 0.05 was considered as statistically significant.
Results
Baseline characteristics are given in Table 1 . Mean followup time was 23.7 months (range, 10-32). According to the Wagner classification, Grades 3 and 4 disease was noted in 36 (48%) and 39 (52%) patients, respectively, in Group 1 and 2 (6.2%) and 30 (93.8%) in Group 2 (χ 2 = 0.018, P = 0.046).
In this study, 18 (16.8%) patients had below-knee, 14 (13%) had Syme's, 9 (8.4%) had metatarsal, 61 (57%) had ray, and 5 (4.6%) had toe amputations ( .38 mg/dL, respectively (P = 0.03), and mean serum albumin level was 3.6 ± 0.72 and 3.64 ± 0.82 g/dL, respectively (P = 0.239).
Mean diabetes duration was 8.49 ± 4.4 years in Group 1 and 9.5 ± 4.32 years in Group 2 (P = 0.045); mean HbA1c was 10.27 ± 2.44% and 11.01 ± 2.71%, respectively (P = 0.675); and a low level of education was noted in 54.6% and 65.6%, respectively (χ 2 = 0.046, P = 0.830). The mean duration of DFU was 4.24 ± 2.41 and 6.31 ± 2.49 months, respectively, in Groups 1 and 2 (P = 0.001), whereas peripheral neuropathy was present in 38 (50.6%) and 9 (28.1%), respectively (χ 2 = 0.025, P = 0.874). Peripheral vascular disease (PVD) was present in 40 (53.3%) and 20 (62.5%), respectively (χ 2 = 0.009, P = 0.926). Although the power analysis was calculated, the mean duration of DFU of both groups was used. The statistical power of the study was calculated as 97.8%. A smoking history was noted in 37 (49.3%) and 22 (68.7%) patients, respectively (χ 2 = 3.334, P = 0.068), whereas 26 (34.6%) and 15 (46.8%) patients, respectively, had a Charcot foot deformity (χ 2 = 1.663, P = 0.197). The main direct cause was inadequate foot care in 39 patients (52%) in Group 1 and 17 (53.1%) in Group 2, followed by direct trauma in 9 (12%) and 17 (53.1%), respectively (χ 2 = 1.890, P = 0.169; χ 2 = 1.103, P = 0.294). There was no significant difference among the groups in terms of the number of comorbidities (χ 2 = 12.998, P = 0.369). Six patients had no additional disease (4 in Table 4 ).
Discussion
We determined risk factors and clinical outcomes of major and minor LEA in 107 patients treated for diabetic foot disease. The main findings showed that age, duration of DM, duration of DFU, CRP count, Wagner classification, and length of hospitalization of major LEA were significantly different compered to minor LEA. DFU and amputations are acute health and socioeconomic problems that negatively affect the quality of life for diabetic patients and additionally create a high economic burden for patients and society (3, 5, 14) . DM is the leading cause of amputations with an accounted rate of 40% of total amputations (15) .
In our study, the proportion of patients with Wagner Grade 4 was higher in the major LEA group than in the minor LEA group. Sun et al. (16) showed that the risk of amputation was strongly associated with high Wagner grade classifications. Similarly, in other studies, Wagner classification was reported to be a predictor of LEA (6, 10, 17) .
Low serum albumin and high HbA1c levels have been reported to be risk factors for limb loss in cases of diabetic foot (10, 18) . Serum albumin is used as a measure to evaluate the nutritional status of the human body. Therefore, a low serum albumin level implies poor nutrition, which causes delayed wound healing (10) . The mean HbA1c value is used to indicate the level of diabetic control. HbA1c is a risk factor for major amputation, which underlines the importance of controlling the underlying diabetes from the point of view of functional prognosis, as well. Lehto et al. (19) reported that plasma glucose levels and the risk of amputation increase in a largely linear fashion. In our study, we found no significant differences between the major and minor amputation groups in terms of serum albumin and HbA1c levels.
Baseline levels of acute phase reactants were associated with increased amputation risk (6, 20) . In recent studies, baseline CRP and sedimentation levels were reported to be independent predictors of major amputations (6). Lipsky et al. (20) showed that increased baseline levels of acute phase reactants (WBC, CRP, and sedimentation) were associated with clinical failure in diabetic foot infections treated with broad-spectrum antibiotics. In our study, CRP levels were significantly different in the major compared to the minor amputation group.
Foot problems are common in diabetic patients over 40 years of age and are thought to increase with age (2, 6, 10) . Amputations associated with diabetic foot have been reported to be more common in men than women. In our study, the mean age of patients in the major amputation group was significantly higher than that of the minor amputation group. Most patients were male, concordant with the literature. In contrast, decreasing age has been reported to be an independent predictor of increased ulcer risk (2) . Although the reason for this finding is unclear, it may be because older patients are probably less mobile than younger patients and less exposed to potentially traumatic situations for the foot at risk (2) .
A relationship between the development of diabetic foot and duration of DM has been reported (21) . The proportion of cases of diabetic foot leading to major amputation significantly increases with increasing duration of DM (18, 21) . In our study, the duration of DM is at least 5 years in 91.5% of the patients with diabetic foot. However, the duration of DM and DFU was significantly higher in patients undergoing major amputation.
Clinical studies have reported that the measure of peripheral neuropathy was the main predicting factor for DFU (22) . Other associations with DFU are PVD, limited Figure 1 . a, b, c) Appearance before and after surgical interventions of Wagner's Grade 4 disease in a diabetic foot patient. joint mobility, foot deformities, and duration of DM with limited relevance (2, 23) . Case-control and prospective studies have confirmed that the 10-g monofilament test was one of the strongest independent risk factors for foot ulcers in diabetics (2, 5, 13, 23) . The most important risk factor for peripheral neuropathy, diabetic foot syndrome, was 43.9% in our study. Although the PVD rate was not significantly different between the groups, 56% of all cases had PVD. Furthermore, hemodialysis was an independent risk factor of major limb amputation. Hemodialysis is the final picture of renal microangiopathy and is a growing problem for foot lesions in dialysis patients with diabetic nephropathy. The frequency of amputation is about 10 times higher in patients on dialysis due to diabetes than in those without dialysis (24) .
Diabetic foot syndrome is a health problem with high morbidity and mortality rates. Additionally, it creates an economic burden due to lengthy hospital stays and hospital costs (4, 5, 14) . Mean hospital stay for diabetic patients was reported to be two times longer than for nondiabetic patients, and hospital costs for diabetic patients were three times higher than for nondiabetic patients (14) . In our study, hospital stay was significantly longer in the major amputation group.
Previous studies suggest that foot infection is a risk factor in major amputation (25) . In our study, all deep tissue cultures were positive, except in 4 patients (3 in Group 1, 1 in Group 2). Generally, in severe diabetic foot infections there is more than one microorganism (26) . Pathogens are generally gram-positive bacteria; however, very serious life-threatening infections with gramnegative agents can be isolated (27) . S. aureus, coagulasenegative Staphylococcus, and group B Streptococcus are the most frequently isolated bacteria (26) (27) (28) . In our patient group, the four most frequently isolated bacterial agents were methicillin-sensitive S. aureus (39.2%), Acinetobacter baumannii (21.4%), methicillin-resistant S. aureus (13%), and group B Streptococcus (12.2%), respectively. However, the number of polymicrobial agents was significantly higher in Group 1.
Empirical antibiotic treatment should be planned according to the severity of diabetic foot infection and possible etiologic agents. It may be sufficient to use antibiotics, which are effective in aerobic gram-positive roots in patients with no history of antibiotic use and with mild-moderate infections. However, in patients with advanced-stage diabetic foot infections, a broader spectrum of antibiotics may be required when selecting empirical antibiotics (26) (27) (28) .
The present study was limited by its small patient population. Another limitation of our study was its retrospective character.
In conclusion, rigorous control of diabetes as the primary disease is first required to avoid major amputations from foot lesions and a marked reduction in postoperative activity in daily life. For early treatment, early detection of lesions and foot care are also important. Diabetic foot is a disease with high morbidity. Although the differences between minor and major diabetic foot amputations are not marked by sharp boundaries, age, Wagner classification, duration of DM, duration of DFU, and CRP level may be risk factors for major amputation.
